{"entity":{"id":"nct06616389","kind":"trial","name":"Study of ODX (OsteoDex) in Multiple Myeloma","aka":[],"tldr":"A phase 1/2 trial of ODX (Osteodex) in multiple myeloma, run by DexTech Medical AB, now recruiting.","summary":"Study of ODX (OsteoDex) in Multiple Myeloma is a phase 1/2 interventional study registered as NCT06616389 by DexTech Medical AB, with 12 participants planned, started 2023-11-29 and due to reach its primary completion in 2026-01-30. Interventions recorded: ODX (Osteodex).","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06616389","url":"https://clinicaltrials.gov/study/NCT06616389"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["multiple-myeloma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06616389","phase":"1/2","setting":"A Phase I/IIa Study of ODX (OsteoDex) in Multiple Myeloma","sponsor":"DexTech Medical AB","participation":[{"nct":"NCT06616389","source":"https://clinicaltrials.gov/study/NCT06616389","fetchedAt":"2026-10-07T16:54:51.841Z","studySha256":"fbdb928665c65e65c76ae8779bac14780855bbe813701325e5a547a10dfc9b0d","overallStatus":"RECRUITING","lastUpdatePosted":"2025-08-19","leadSponsor":"DexTech Medical AB","collaboratorCount":0,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":12,"enrolmentType":"ESTIMATED","siteCount":2,"recruitingSiteCount":2,"countries":["Sweden"]}],"started":"2023-11-29","startedType":"actual","enrolled":12,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06616389/","neighbours":{"cancer":[{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/"}]}}